Participants 65 87 3
cancer-related fatigue
Participants 289 311 3
cancer-related fatigue
Participants 363 390 5
Eligible adults with cancer
Participants 748 775 7
Two hundred ninety patients
Participants 1027 1040 3
placebo group
Participants 1046 1061 3
50 mg/day group
